These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21440104)

  • 21. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
    Aliabadi HM; Mahmud A; Sharifabadi AD; Lavasanifar A
    J Control Release; 2005 May; 104(2):301-11. PubMed ID: 15907581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
    Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
    J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.
    Chiappetta DA; Sosnik A
    Eur J Pharm Biopharm; 2007 Jun; 66(3):303-17. PubMed ID: 17481869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel.
    Gou M; Li X; Dai M; Gong C; Wang X; Xie Y; Deng H; Chen L; Zhao X; Qian Z; Wei Y
    Int J Pharm; 2008 Jul; 359(1-2):228-33. PubMed ID: 18448286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.
    Aliabadi HM; Brocks DR; Lavasanifar A
    Biomaterials; 2005 Dec; 26(35):7251-9. PubMed ID: 16005061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical review: topical ophthalmic use of cyclosporin A.
    Utine CA; Stern M; Akpek EK
    Ocul Immunol Inflamm; 2010 Oct; 18(5):352-61. PubMed ID: 20735287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent patents and advances in ophthalmic drug delivery.
    Janoria KG; Hariharan S; Dasari CR; Mitra AK
    Recent Pat Drug Deliv Formul; 2007; 1(2):161-70. PubMed ID: 19075883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.
    Calvo P; Vila-Jato JL; Alonso MJ
    J Pharm Sci; 1996 May; 85(5):530-6. PubMed ID: 8742946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
    Devalapally H; Shenoy D; Little S; Langer R; Amiji M
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing an in situ nanosuspension: a novel approach towards the efficient administration of poorly soluble drugs at the anterior eye.
    Luschmann C; Tessmar J; Schoeberl S; Strauss O; Framme C; Luschmann K; Goepferich A
    Eur J Pharm Sci; 2013 Nov; 50(3-4):385-92. PubMed ID: 23880334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels.
    Kapoor Y; Chauhan A
    Int J Pharm; 2008 Sep; 361(1-2):222-9. PubMed ID: 18577433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.
    Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A
    J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colloidal drug delivery system: amplify the ocular delivery.
    Ali J; Fazil M; Qumbar M; Khan N; Ali A
    Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pegylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether.
    Bhadra D; Bhadra S; Jain NK
    J Pharm Pharm Sci; 2005 Sep; 8(3):467-82. PubMed ID: 16401394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
    Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
    Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug delivery systems for cyclosporine: achievements and complications.
    Klyashchitsky BA; Owen AJ
    J Drug Target; 1998; 5(6):443-58. PubMed ID: 9783676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
    Gursoy RN; Benita S
    Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copolymers.
    Letchford K; Zastre J; Liggins R; Burt H
    Colloids Surf B Biointerfaces; 2004 May; 35(2):81-91. PubMed ID: 15261040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.